Business Wire

Siemens, PSE to Collaborate on Model-Based Solutions

Del

Achema 2018, Hall 11, Booth C3 - Siemens AG and Process Systems Enterprise (PSE), the Advanced Process Modelling (APM) company, today announced at Achema that they have signed a long-term collaboration agreement to bring the power of PSE’s gPROMS APM technology to Siemens automation and digitalization offerings for the process industries. Under the agreement, the companies are bringing to market a new set of solutions for long-term equipment and health monitoring, soft-sensing, prediction of future process performance, real-time optimisation, and operator training incorporating high-fidelity models. The solutions are all based on the combination of process models that embody deep process knowledge with real-time as well as historical plant data.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612006377/en/

Siemens, PSE to Collaborate on Model-Based Solutions (Photo: Business Wire)

Siemens, PSE to Collaborate on Model-Based Solutions (Photo: Business Wire)

Typical customer benefits of such applications include better operations through enhanced, up-to-the-minute decision support information; improved maintenance scheduling through run length prediction; improved economics from real-time optimisation; and improved asset integrity from better health monitoring.

The technologies are capable of driving next-level productivity enhancements to operations in the Chemicals & Petrochemicals, Oil & Gas, Refining, Pharmaceutical, Food & Beverage and Water industries. Future developments will see similar model-based approaches integrated over the whole lifecycle of a process plant.

At Achema, Siemens and PSE are demonstrating digital process twin technology for an ethylene plant, implemented using PSE’s gPROMS Olefins Operational Excellence tools. Industrial application of such techniques on a large-scale ethylene plant has demonstrated a two percent improvement in yield. Also demonstrated are a soft sensing application and model predictive control for a continuous wet granulation tablet manufacturing in pharma.

Eckard Eberle, CEO of the Process Automation Business Unit (PD PA) and Director in charge of the Siemens booth at the Achema, says: “Siemens has already made Integrated Engineering a reality; by collaborating with PSE, we are taking a further step into model-based operations with two very complementary sets of technologies. This is digitalization at its best.” Costas Pantelides, MD of PSE, says: “The combination of high-fidelity predictive models and real-time data is enormously powerful. This is a time of extraordinary opportunities for the process industries, made possible by the culmination of many years of development in advanced modelling and in the enabling computer science and mathematics”.

Pantelides concludes: “There is an increasingly compelling case for capturing deep process knowledge in the form of predictive models, which can come naturally from R&D and engineering design activities, then using these within a digitalization framework to generate value at every step.”

This press release is available at
www.siemens.com/press/PR2018060207PDEN
www.psenterprise.com/news/pr180612

For further information on Siemens and PSE at Achema 2018, please see www.siemens.com/achema and
www.psenterprise.com/events/emea/achema-2018

Contact information

Contacts for journalists
PSE:
Kate Burness
Phone: +44-20-8563-0888
E-mail: k.burness@psenterprise.com
or
Evelyne Kadel
Phone: +49 (0)211 6916-1003
E-mail: evelyne.kadel@siemens.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Abu Dhabi to Host Interfaith Alliance For Safer Communities: Child Dignity in the Digital World Forum on 19 November17.11.2018 13:40Pressemelding

Held under the patronage of His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces, the UAE will host the first edition of the Interfaith Alliance For Safer Communities Forum on November 19-20 in recognition of the country’s leading role in promoting tolerance and interfaith dialogue. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181117005008/en/ His Highness Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Deputy Supreme Commander of the UAE Armed Forces (Photo: AETOSWire) The forum will host 450 guests including religious leaders, NGOs and heads of industry to discuss ongoing social challenges and develop comprehensive solutions for protecting youth from cybercrime. The Interfaith Alliance For Safer Communities Forum is an expansion of the Child Dignity in the Digital World Congress which was held in October 2017 in the Vatican, an

Philip Morris International and Dorna Switch Gears in Quest for a World without Tobacco Smoke17.11.2018 11:00Pressemelding

Philip Morris International Inc. (PMI) (NYSE:PM) and Dorna Sports S.L., the commercial rights holder for the world FIM MotoGP Championships, have extended their partnership until the end of 2021. The two organizations have collaborated successfully for 26 years. As of 2019, the partnership will focus on advancing the cause of a smoke-free world. More than 1 billion people smoke today and, according to the World Health Organization, will continue to smoke in the near future. PMI has committed to transform its business and encourage all men and women who would otherwise continue smoking to replace cigarettes with better alternatives as soon as possible. With around 350 million MotoGP fans worldwide, MotoGP can play a significant role in positively impacting the lives of people who smoke and those around them. “The best choice for consumers concerned about the health risks of smoking is to quit tobacco and nicotine altogether. Today, however, technology, science and innovation provide a r

Schlumberger Announces Fourth-Quarter and Full-Year 2018 Results Conference Call16.11.2018 18:00Pressemelding

Schlumberger Limited (NYSE:SLB) will hold a conference call on January 18, 2019 to discuss the results for the fourth quarter and full year ending December 31, 2018. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until February 18, 2019, and can be accessed by dialing +1 (800)

Visa Strengthens Commitment to Growing Digital Payments in India16.11.2018 14:33Pressemelding

Visa (NYSE: V) today announced a minority investment in BillDesk, a leading platform for online payments and bill payments in India. Visa’s investment and collaboration will help BillDesk develop new product lines for its payments and loyalty businesses and also expand its footprint into other geographies. The investment will be subject to necessary statutory approvals and is expected to have no direct bearing on Visa’s existing Indian business. “As a leading payments player in India, BillDesk has been a long time business partner to Visa. Having worked with BillDesk’s founders over the years, the Visa leadership has been consistently impressed with their vision, market knowledge and execution capabilities, as well as alignment on values. This investment further reinforces our long-term commitment to India’s digital payments growth story,” said Asia Pacific regional president, Chris Clark. “We are truly excited by this investment from the world's largest global payment network, Visa. W

Guidewire Enhances PartnerConnect Consulting Program with Addition of Product and Regional Specializations16.11.2018 13:55Pressemelding

Guidewire Software, Inc. (NYSE: GWRE), provider of the industry platform Property and Casualty (P&C) insurers rely upon, today announced the addition of specializations to its PartnerConnect Consulting program. Specializations have been added to aid insurance companies in selecting the best partner to lead or staff their Guidewire projects. Guidewire unveiled new specializations, including two which have been successfully piloted earlier this year. “Our customers will now have more clarity and information as to which partners have the proven capabilities in their chosen product and region,” said Lisa Walsh, vice president, Alliances, Guidewire Software. “Adding these specializations will also allow us to have more insight into a partner’s performance and competencies.” To earn a specialization, partners need to demonstrate skills, knowledge, and competency in a specific Guidewire product or solution by certifying staff at multiple levels (specialist and professional) through Guidewire’

Janssen receives positive CHMP opinion for ERLEADA™ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer who are at high risk of developing metastatic disease16.11.2018 13:15Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for apalutamide, a next generation oral androgen receptor inhibitor for the treatment of adult patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.2 The CHMP’s positive opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the use of apalutamide. The CHMP’s positive opinion is based on data from the pivotal SPARTAN Phase 3 clinical study which assessed the safety and efficacy of apalutamide versus placebo in patients with nmCRPC who have a rapidly rising prostate specific antigen (PSA) level despite receiving continuous androgen deprivation therapy (ADT). The SPARTAN clinical study showed that apalutamide, when added to ADT, significantly reduced the risk